Searched for
CDSCO REPORT
Why CDSCO and BEE have not kept pace with the industries they overseeCDSCO still faces challenges like chronic understaffing, gaps in technical skills, weak lab infra and fragmented approvals. About a decade ...- Punjab drug body finds critical lapses at Jackson Laboratories' manufacturing facility in AmritsarThe Punjab FDA has taken decisive action by revoking the manufacturing licence of Jackson Laboratories in Amritsar due to severe regulatory...
- WHO seeks details from India over oxytocin-linked deaths; licences of manufacturer cancelledThe World Health Organisation (WHO) has sought details from the Indian government after reports linked oxytocin injections made by Jackson ...
- Central Drugs Laboratories find 46 drug samples not of standard quality for MayHealth officials revealed that in May 2026, 46 drug samples tested by Central Drugs Laboratories and 113 by State Drugs Testing Laboratorie...
- The hidden cost of looking better: What health insurance covers, and what it leaves you to payRising demand for weight-loss drugs, cosmetic procedures and wellness treatments is creating a growing out-of-pocket healthcare expense cat...
- Banned substance in shrimp: Vet shops under close watchIndia's top drug regulator is cracking down on veterinary shops. This action follows a significant rejection of shrimp exports to major mar...
- Drug companies directed to step up vigil on adverse reactionsIndia's drug regulator, CDSCO, has mandated all drug companies to establish systems for tracking adverse drug reactions. This move comes am...
- No cosmetic job with jabs, warns drug regulator CDSCOThe notice issued by the Central Drugs Standard Control Organisation (CDSCO) cites provisions of the Drugs and Cosmetics Act, 1940, and the...
- Drugmakers must report safety data from launch date, not approval date: CDSCOIndia's drug regulator has issued a new directive for pharmaceutical companies. Periodic Safety Update Reports for new drugs must now be su...
- Drug regulator cracks down on delayed safety reporting by pharma companiesIndia's drug regulator CDSCO has issued new rules for drug safety reporting. Companies must now submit safety reports from the actual launc...
- ED raids seven Chennai sites linked to Sresan Pharma over Coldrif cough syrup deathsThe Enforcement Directorate (ED) conducted searches at seven locations in Chennai concerning the Coldrif cough syrup case. These raids, und...
- Parl panel on health: Cos scared to set up units due to CDSCO approachThe Parliamentary Standing Committee on Health and Family Welfare criticized the Central Drugs Standard Control Organisation (CDSCO) for de...
- Calcium, Vitamin D3 tablets, 47 others fail CDSCO's quality check: Check if your medication is safe?The Central Drugs Standard Control Organisation (CDSCO) identified 49 drugs failing quality tests in its September report. Among these are ...
- Alkem Labs denies claims of Pan-D, Clavam 625 batches being not-of-standard qualityAlkem Laboratories has denied claims that its products Pan-D and Clavam 625 are of substandard quality. The company stated that an investig...
- Did not manufacture drugs flagged in CDSCO report, say leading pharma companiesDrug companies like Sun Pharma and Torrent Pharma have refuted claims in a CDSCO report that flagged certain medicines as "counterfeits". T...
- Torrent Pharma refutes claims product Shelcal 500, failed quality test by CDSCOTorrent Pharmaceuticals has denied claims that its popular product Shelcal 500 failed a quality test by the Central Drug Standards Control ...
- Rx quality control for reputation and livesReplace the existing regulatory system with a modern legal structure that provides oversight to an increasingly complex pharma industry, wh...
- 'Media Reports on Admission of Vax Side-effects by ICMR Erroneous'Citing an RTI (Right to Information Act) response, the news report had claimed that ICMR and CDSCO officials have admitted to side-effects ...
- Media report on 'multiple side-effects of Covid vaccines' ill-informed, erroneous: Health MinistryIn line with the policy of the Union Ministry of Health of proactive disclosure aligned with global scientific evidence in the public domai...
- J&J’s subsidiary hip replacement row: A detailed timeline of events that hit this global giantJ&J has already paid $2.5 billion in settlements in the US, while Indian victims may receive a minimum payout of Rs 20 lakh each after an a...
Load More
